News
Latest News About Asthma, Allergies, and Related Conditions
AAFA can connect you to all of the information and resources you need. We provide the latest information about asthma and allergic diseases in a variety of formats. You can sign up to follow our blogs or receive our newsletters. To stay up to date on the Foundation’s announcements, check out our press releases as well.
If you are a member of the press, and need to speak with an asthma or allergy expert for your story, please contact a member of AAFA’s communications team at (202) 974-1223 or email gro.afaa@aidem.
Press Releases
Maryland Becomes Fourth State to Enact Elijah’s Law to Protect Kids with Food Allergies
NewsAAFA celebrates action to make child care centers safer Washington, DC, April 26, 2024 – The Asthma and Allergy Foundation of America (AAFA) celebrates the signing of Elijah’s Law in Maryland. The legislation, passed by the Maryland House and...
Digihaler Discontinuation May Cause Another Disruption in Care for People with Asthma
NewsAAFA urges patients to work with providers to find alternative treatment options Washington, DC, April 15, 2024 – In response to news that drug manufacturer Teva plans to discontinue U.S. distribution of its Digihaler® products, the Asthma and...
AAFA’s Advocacy for Health Equity Leads to White House Address on Asthma Inhaler Pricing
NewsPresident Biden and Senator Sanders spotlight asthma in fight to reduce health care costs Washington, DC, April 3, 2024 – As the leading advocacy organization focused on improving the access and affordability of asthma inhalers, the Asthma and...
AAFA Welcomes News of Lower Costs for GSK Asthma Inhalers
NewsTrend toward $35 monthly cost cap for inhalers a big win for millions of people with asthma Washington, DC, March 20, 2024 – The Asthma and Allergy Foundation of America (AAFA) welcomes an announcement from drug manufacturer GSK that the company...
AAFA Statement on EPA Cars Rule
News"A zero emissions future will make breathing easier for people with asthma” Washington, D.C., March 20, 2024 – The Asthma and Allergy Foundation of America (AAFA) applauds a new rule by the Environmental Protection Agency (EPA) that will drive...
AAFA Statement in Response to AstraZeneca Asthma Inhaler Cost Announcement
NewsPatient advocacy group continues push to reduce costs, improve access Washington, D.C., March 18, 2024 – The Asthma and Allergy Foundation of America (AAFA) welcomes efforts to make asthma medicines more affordable and accessible. AAFA continues...
Report: Climate Change Makes Living with Allergies a Challenge
NewsAAFA’s 2024 Allergy Capitals™ report names most challenging cities for living with allergies Washington D.C., March 14, 2024 — The Asthma and Allergy Foundation of America (AAFA) released its 2024 Allergy Capitals™ report detailing the most...
AAFA Statement on Asthma Inhaler Price Caps
NewsPatient advocacy group applauds efforts to make asthma medicine more affordable Washington, D.C., March 8, 2024 – The Asthma and Allergy Foundation of America (AAFA) is leading advocacy efforts to change the drug pricing ecosystem and to make...
AAFA Statement on Uber Eats Super Bowl Ad
NewsPatient advocacy group calls on Uber to be a friend to the food allergy community Washington, D.C., February 8, 2024 – The Asthma and Allergy Foundation of America (AAFA) issued the following statement which may be attributed to Kenneth Mendez,...
AAFA Applauds Senate Investigation into Pricing of Asthma Inhalers
NewsPatient advocacy group calls for action to break down barriers that prevent access to and limit affordability of asthma treatment Washington D.C. – January 9, 2024 The Asthma and Allergy Foundation of America (AAFA) today applauded the...
